Detalles de la búsqueda
1.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol;
21(3): 771-788.e10, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152897
2.
Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
Dig Dis;
41(2): 239-249, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323226
3.
[Position paper on reporting of intestinal ultrasound findings in patients with inflammatory bowel disease]. / Positionspapier zur Befunderhebung von Darmultraschallbefunden bei chronisch entzündlichen Darmerkrankungen.
Z Gastroenterol;
60(6): 978-990, 2022 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-35671995
4.
Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany: Retrospective Analysis of a Large Prescription Database.
J Clin Gastroenterol;
55(1): e1-e7, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011403
5.
A Prospective Multicenter Study on the Prevalence of Fructose Malabsorption in Patients with Chronic Inflammatory Bowel Disease.
Digestion;
102(3): 397-403, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32516791
6.
Expression of the fructose transporter GLUT5 in patients with fructose malabsorption.
Z Gastroenterol;
59(6): 531-539, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34130330
7.
Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study.
Gut;
69(9): 1629-1636, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31862811
8.
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review.
BMC Gastroenterol;
20(1): 211, 2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640990
9.
Comparative Analysis of the 3-Year Persistence Rate with Second-Line Vedolizumab and Tumor Necrosis Factor-α Inhibitors in Patients with Inflammatory Bowel Disease Followed in Gastroenterology Practices in Germany.
Dig Dis;
38(6): 466-473, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045927
10.
Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
Z Gastroenterol;
58(10): 982-1002, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33036052
11.
Predictive parameters for the clinical course of Crohn's disease: development of a simple and reliable risk model.
Int J Colorectal Dis;
34(10): 1653-1660, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446480
12.
The Predictive Value of the Hydrogen Breath Test in the Diagnosis of Fructose Malabsorption.
Digestion;
99(2): 140-147, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30179874
13.
[Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease with regard to COVID-19 (version 2.0)]. / Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0).
Z Gastroenterol;
62(4): 517-534, 2024 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-38599579
14.
Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease.
Mod Pathol;
31(3): 527-538, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29192648
15.
Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.
Clin Gastroenterol Hepatol;
15(4): 535-542.e2, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27856365
16.
Proposal for an anti-TNF-exit strategy based on trough serum level.
Biologicals;
47: 81-85, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28400083
17.
Aktualisierte S3-Leitlinie "Diagnostik und Therapie des Morbus Crohn" der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) August 2021 AWMF-Registernummer: 021-004.
Z Gastroenterol;
60(3): 332-418, 2022 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-35263784
18.
CT-P13 (Inflectra™, Remsima™) monitoring in patients with inflammatory bowel disease.
Biologicals;
44(5): 463-6, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27435444
19.
[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers]. / Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie offene Fragen und Antworten.
Z Gastroenterol;
58(7): 672-692, 2020 Jul.
Artículo
en Alemán
| MEDLINE | ID: mdl-32659830
20.
[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers]. / Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie offene Fragen und Antworten.
Z Gastroenterol;
58(7): e367, 2020 Jul.
Artículo
en Alemán
| MEDLINE | ID: mdl-33545734